Rebecca Rubin Film and Media ReporterAre comic book movies bulletproof at the box office?After Sony’s antihero adventure “Morbius” managed to pull in $39.1 million over the weekend despite terrible reviews, the answer is… sorta?There are a few ways to slice the opening weekend revenues for “Morbius,” a $75 million-budgeted superhero tentpole from Sony’s Universe of Marvel Characters.
Ticket sales weren’t even close to matching 2018’s “Venom” ($80 million debut) and its 2021 sequel “Let There Be Carnage” ($90 million debut), which were Sony’s first attempts at spinning Spider-Man adversaries — the characters the studio licenses from Marvel — into cinematic riches.
But business could have been way, way worse considering “Morbius” has a 17% on Rotten Tomatoes — an average score that’s somehow lower than “Venom” and its embarrassing 30% mark. “Sometimes there is a disconnect between the critical consensus and the sentiment of the fan base for whom ‘Morbius’ was still a ‘must see’ moviegoing event,” says Paul Derbarabedian, a senior media analyst with Comscore.So where does that leave “Morbius”?
Well, it’s a sign that superheroes can galvanize ticket buyers in ways that few other genres can. But it’s also an indication that not every Marvel character has blockbuster potential.
Read more on variety.com
Get the latest stars news and celebrity rumours with exclusive stories, photos, videos and interviews.
Breaking up, scandals, engagements, divorces, gossip – all you need to know about the private lives of your favorite celebs.
Get to know the latest showbiz news along with exclusive interviews and even more. All this is waiting for you on the main page 24 hours a day, 7 days a week! Who, where, when, with whom, how, why and for what!? Stay tuned to know first!
Just follow us daily and we will provide you with the current news from the life of famous stars and celebrities.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.